BRIEF published on 09/02/2024 at 22:10, 13 days 22 hours ago Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA Approval Sleep Apnea Nyxoah U.S. Market Launch Genio® Device
BRIEF published on 09/02/2024 at 22:10, 13 days 22 hours ago Nyxoah sonne la cloche de clôture du Nasdaq tout en se préparant au lancement sur le marché américain d'un dispositif innovant contre l'apnée du sommeil Approbation De La FDA Apnée Du Sommeil Nyxoah Lancement Sur Le Marché Américain Appareil Genio®
PRESS RELEASE published on 09/02/2024 at 22:05, 13 days 22 hours ago Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device Nyxoah rings the Nasdaq Closing Bell as it prepares for the U.S. market launch of its innovative sleep apnea device, Genio. FDA approval expected by end of 2024 FDA Approval Nasdaq Sleep Apnea Nyxoah Genio
BRIEF published on 08/06/2024 at 22:10, 1 month 9 days ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
BRIEF published on 08/06/2024 at 22:10, 1 month 9 days ago Nyxoah publie ses résultats financiers pour le deuxième et le premier semestre 2024 Augmentation De Capital Hausse Des Revenus Faits Saillants Opérationnels Soumission À La FDA Résultats Du Deuxième Trimestre 2024
PRESS RELEASE published on 08/06/2024 at 22:05, 1 month 9 days ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 2 months 1 day ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/15/2024 at 08:20, 2 months 1 day ago Nyxoah nomme Scott Holstine au poste de directeur commercial Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Scott Holstine Industrie Des Dispositifs Médicaux
PRESS RELEASE published on 07/15/2024 at 08:15, 2 months 1 day ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 2 months 13 days ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
Published on 09/16/2024 at 20:15, 35 minutes ago New to the Street's Episode 601 Will Air as Sponsored Programming on Fox Business at 10:30 PM PST, September 16, 2024. This Special Episode Will Feature In-Depth Interviews and Profiles of Industry-Leading Companies Driving Innovation in Their Respective
Published on 09/16/2024 at 20:07, 43 minutes ago Nexera Provides Update#2 on Delayed Filing of Annual Financial Statements and MD&A and Management Cease Trade Order
Published on 09/16/2024 at 20:00, 50 minutes ago Lender Market Unveils AI-Powered Financial Advisor Service for Business Owners
Published on 09/16/2024 at 19:30, 1 hour 20 minutes ago Gabriel Resources Ltd. - Resignation of Director
Published on 09/16/2024 at 19:30, 1 hour 20 minutes ago Gamehost Announces Regular Monthly Dividend for September
Published on 09/16/2024 at 18:32, 2 hours 18 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/16/2024 at 18:19, 2 hours 31 minutes ago BILENDI: Bilendi dévoile 2 projets basés sur son intelligence artificielle générative BARI présentés au congrès mondial ESOMAR
Published on 09/16/2024 at 17:59, 2 hours 50 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 September 2024
Published on 09/16/2024 at 16:16, 4 hours 34 minutes ago Original-Research: Netfonds AG (von Montega AG): Kaufen
Published on 09/16/2024 at 15:28, 5 hours 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Report on the Combined General Meeting of the 12th of September 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Compte-rendu d’Assemblée Générale Mixte du 12 septembre 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Programme de rachat d’actions propres : Déclaration des transactions sur actions propres réalisées du 9 septembre 2024 au 13 septembre 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Share buy-back program: Disclosure of trading in own shares from 9 September 2024 to 13 September 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago imerys-16-09-2024-communique-capital-droits-de-vote-au-31-juillet-2024